docetaxel anhydrous has been researched along with Peripheral Nerve Diseases in 74 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (6.76) | 18.2507 |
| 2000's | 19 (25.68) | 29.6817 |
| 2010's | 36 (48.65) | 24.3611 |
| 2020's | 14 (18.92) | 2.80 |
| Authors | Studies |
|---|---|
| Ligtenberg, M; Steegers, M; van den Heuvel, S; van Haren, F; Vissers, K | 1 |
| Cao, M; Li, H; Lv, Z; Ma, F; Mo, H; Pan, B; Song, G; Sun, X; Teng, Y; Xu, B; Yan, X; Zhai, J; Zhao, F; Zhao, J | 1 |
| Eto, T; Hara, M; Ijichi, H; Koga, C; Misumi, N; Nakamura, Y; Okamoto, M; Tajiri, W; Tokunaga, E | 1 |
| Eguchi, S; Hidaka, M; Kuba, S; Matsumoto, M; Morita, M; Nagayasu, T; Otsubo, R; Sakimura, C; Yamanouchi, K; Yano, H | 1 |
| Chan, YN; Chen, CY; Jheng, YW; Lin, MW; Wang, PJ; Wang, YJ | 1 |
| Bland, KA; Bovard, J; Campbell, KL; Davis, MK; Gelmon, KA; Kirkham, AA; McKenzie, DC; Shenkier, T; Zucker, D | 1 |
| Ang, E; Ang, S; Bandla, A; Chan, A; Chan, G; Hairom, Z; Huang, Y; Kumarakulasinghe, NB; Lee, SC; Lee, YM; Lim, JSJ; Magarajah, G; Ngoi, N; Sundar, R; Tan, S; Thakor, N; Wilder-Smith, E; Wong, A | 1 |
| Beijers, AJM; Bonhof, CS; de Vos-Geelen, J; Jacobs, EMG; Mols, F; Ophorst, J; van de Poll-Franse, LV; Vreugdenhil, G | 1 |
| Matta, C; Mensah-Nyagan, AG; Meyer, L; Taleb, O | 1 |
| Jin, L; Yang, W; Zhang, Y | 1 |
| Fujiwara, Y; Hasegawa, J; Hashimoto, K; Ikeda, K; Kawabata, H; Nishizawa, D; Ozaki, Y; Shimizu, C; Shimomura, A; Shiraishi, S; Takano, T; Tamura, K; Tamura, N; Tanabe, Y; Yonemori, K; Yunokawa, M | 1 |
| Eguchi, S; Kanetaka, K; Kuba, S; Matsumoto, M; Morita, M; Nagayasu, T; Otsubo, R; Sakimura, C; Yamanouchi, K; Yano, H | 1 |
| Hertz, DL | 1 |
| Anai, S; Fujimoto, K; Ichikawa, K; Miyake, M; Nakai, Y; Tanaka, N | 1 |
| Hiraiwa, R; Iguma, Y; Imai, S; Iwamitsu, Y; Kawaguchi-Sakita, N; Kotake, T; Koyanagi, M; Matsubara, K; Matsumoto, M; Nagayasu, K; Nakagawa, S; Nakagawa, T; Ntogwa, M; Ogihara, T; Omura, T; Saigo, M; Yonezawa, A | 1 |
| Finnerup, NB; Fuglsang-Frederiksen, A; Isak, B; Pugdahl, K; Tankisi, H; Ventzel, L | 1 |
| Hosokawa, T; Inagaki, M; Kanbayashi, Y; Ueno, H | 1 |
| Moeller, M; Moore, HCF; Mustafa Ali, M; Rybicki, L | 1 |
| Bandos, H; Brufsky, AM; Fehrenbacher, L; Ganz, PA; Julian, TB; Margolese, RG; McCarron, EC; Melnikow, J; Rivera, DR; Sturtz, K; Swain, SM; Wade, JL | 1 |
| Finnerup, NB; Fuglsang-Frederiksen, A; Isak, B; Jensen, AB; Jensen, AR; Jensen, TS; Karlsson, P; Madsen, CS; Tankisi, H; Ventzel, L | 1 |
| Eguchi, S; Hayashida, N; Kanetaka, K; Kobayashi, K; Kuba, S; Morita, M; Sakimura, C; Takatsuki, M; Yamanouchi, K | 1 |
| Bae, J; Chae, SI; Chung, YH; Jeong, JH; Kim, ST; Kyung, EJ; Lee, HS; Lee, JH; Lee, TJ; Lee, WM; Park, ES; Sohn, UD; Suh, JS | 1 |
| Endo, K; Kuriyama, A | 1 |
| Bandapalli, OR; Campo, C; da Silva Filho, MI; Försti, A; Goldschmidt, H; Hemminki, K; Mahmoudpour, SH; Merz, M | 1 |
| Albrecht, TL; Beebe-Dimmer, JL; Greenwald, MK; Ruterbusch, JJ; Schwartz, AG; Simon, MS | 1 |
| Agapito, G; Altomare, E; Arbitrio, M; Arpino, G; Cannataro, M; Caracciolo, D; Di Martino, MT; Fabiani, F; Galeano, T; Grillone, F; Iuliano, E; Santini, D; Scionti, F; Staropoli, N; Tagliaferri, P; Tassone, P | 1 |
| Au, JSK; Chan, A; Chan, CW; Cheng, HL; Leung, KT; Li, YC; Lopez, V; Molassiotis, A; Ng, TR; Suen, LKP; Sundar, R; Wong, KH; Yorke, J | 1 |
| Anders, CK; Basch, E; Carey, LA; Choi, SK; Deal, AM; Dees, EC; Jolly, TA; Karuturi, MS; Kimmick, GG; Lee, JT; Muss, HB; Nyrop, KA; Reeder-Hayes, KE; Reeve, BB; Reinbolt, RE; Shachar, SS; Speca, JC; Wood, WA | 1 |
| Bahl, A; de Bono, JS; Devin, J; Gravis, G; Hansen, S; Kocak, I; Oudard, S; Ozgüroglu, M; Sartor, AO; Shen, L; Tombal, B | 1 |
| Kudlowitz, D; Muggia, F | 1 |
| DeMichele, A; Farrar, JT; Hennessy, S; Mao, JJ; Sammel, MD; Speck, RM; Stineman, MG | 1 |
| Eckhoff, L; Ejlertsen, B; Ewertz, M; Jensen, MB; Knoop, AS | 1 |
| Gao, X; Jing, T; Sun, Y; Wang, F; Xu, C; Zhang, C | 1 |
| da Silva Simão, DA; de Paula Lima, ED; Souza, RS; Teixeira, AL | 1 |
| Bergmann, TK; Eckhoff, L; Ewertz, M; Feddersen, S; Knoop, AS | 1 |
| Burger, RA; Chase, DM; Foss, CD; Huang, H; Monk, BJ; Wenzel, LB | 1 |
| Eckhoff, L; Ewertz, M; Jensen, MB; Knoop, A | 1 |
| Cathomas, R; De Bono, JS; Gillessen, S; Omlin, A; Rothermundt, C; Sartor, O; Shen, L; Su, Z | 1 |
| Castro-Lopes, JM; Dias, T; Fontes, F; Fragoso, M; Lunet, N; Pereira, S; Sonin, T | 1 |
| Finnerup, NB; Jensen, AB; Jensen, AR; Jensen, TS; Ventzel, L | 1 |
| Brewer, JR; Dolan, ME; Fleming, GF; Morrison, G | 1 |
| Gennatas, K; Gennatas, S; Michalaki, V | 1 |
| Alexandre, J; Durand, JP; Goldwasser, F; Mir, O; Pons, G; Tran, A; Treluyer, JM | 1 |
| Bianchi, R; Camozzi, F; Carozzi, V; Cavaletti, G; Cervellini, I; Crippa, D; Lauria, G; Melcangi, RC; Roglio, I | 1 |
| Jaén, P; Muñoz-Zato, E; Pérez, B; Truchuelo, M; Vano-Galvan, S | 1 |
| Bello, E; Bianchi, R; Camozzi, F; Canta, A; Cavaletti, G; Cervellini, I; D'incalci, M; Frapolli, R; Ghezzi, P; Lauria, G; Lombardi, R; Melcangi, RC; Oggioni, N; Porretta-Serapiglia, C; Roglio, I | 1 |
| Cavaletti, G; Chiorazzi, A; Maggioni, D; Meregalli, C; Nicolini, G; Tredici, G | 1 |
| Andersen, M; Pfeiffer, P; Schønnemann, KR; Yilmaz, M | 1 |
| Kip, K; Overcash, J; Tofthagen, C | 1 |
| Barthelemy, N; Chin, SH; Cunningham, JE; Falkowski, P; Kelechi, T; Sterba, K | 1 |
| Honda, K; Imaishi, H; Kamura, T; Takemoto, S; Terada, A; Ushijima, K; Wada, H | 1 |
| Barg, FK; DeMichele, A; Farrar, JT; Hennessy, S; Mao, JJ; Speck, RM; Stineman, MG | 1 |
| Aissi, M; Kubis, N; Lévy, BI; Milani, P; Osmani, K; Vignes, S; Wade, F | 1 |
| Aranishi, T; Hausheer, FH; Katsumata, N; Kuranami, M; Kuroi, K; Makino, H; Morita, S; Ohashi, Y; Ohsumi, S; Shimozuma, K; Suemasu, K; Takeuchi, A; Watanabe, T | 1 |
| Markman, M | 1 |
| Rose, PG; Smrekar, M | 1 |
| Hsu, Y; Sood, AK; Sorosky, JI | 1 |
| Hirono, M; Ikeda, M; Kurebayashi, J; Nakashima, K; Nomura, N; Okubo, S; Sonoo, H; Tanaka, K; Udagawa, K; Yamamoto, Y | 1 |
| Arné-Bès, MC | 1 |
| Furugen, Y; Hata, A; Hata, N; Hata, Y; Kurokawa, A; Mitsuhashi, N; Nishihara, S; Sone, Y | 1 |
| Berman, A; Chow, CK; Danforth, D; Eng-Wong, J; Lebowitz, PF; Liu, E; Merino, MJ; Swain, SM; Venzon, D; Zia, F; Zujewski, J | 1 |
| Atkinson, R; Coleman, R; Gabra, H; Gordon, A; Hay, A; Jayson, GC; Kaye, SB; Parkin, D; Paul, J; Vasey, PA | 1 |
| Hamel, K; Hamolsky, D; Melisko, M; Topp, KS; Wampler, MA | 1 |
| Canta, A; Cavaletti, G; Galbiati, S; Gilardini, A; Giussani, G; Lanzani, F; Mueller, L; Nicolini, G; Persohn, E; Schoepfer, S; Scuteri, A; Traebert, M | 1 |
| Furlow, B | 1 |
| Argiris, A; Axelrod, R; Burtness, BA; Forastiere, AA; Manola, J | 1 |
| Aapro, MS; Ajani, J; Baker, J; Martin, M; Scotté, F; von Minckwitz, G; Winther, D | 1 |
| Foa, R; Norton, L; Seidman, AD | 1 |
| Hilkens, PH; Stoter, G; van den Bent, MJ; van Putten, WL; Vecht, CJ; Verweij, J | 1 |
| Barohn, RJ; Burris, H; Jackson, CE; New, PZ; Rinaldi, D | 1 |
| Hilkens, PH; Stoter, G; van den Bent, MJ; Vecht, CJ; Verweij, J | 1 |
| Bolognesi, A; Bordogna, G; Canal, N; Fazio, R; Nemni, R; Previtali, S; Quattrini, A; Villa, E | 1 |
| Iñiguez, C; Larrodé, P; Mauri, JA; Mayordomo, JI; Morales, F; Trés, A | 1 |
| Ayoub, JP; Cervantes, G; Fumoleau, P; Jones, S; Leonard, R; Lui, WY; Mauriac, L; Miles, D; Moiseyenko, V; O'Shaughnessy, J; Twelves, C; Van Hazel, G; Verma, S; Vukelja, S | 1 |
11 review(s) available for docetaxel anhydrous and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Exploring pharmacogenetics of paclitaxel- and docetaxel-induced peripheral neuropathy by evaluating the direct pharmacogenetic-pharmacokinetic and pharmacokinetic-neuropathy relationships.
Topics: Animals; Antineoplastic Agents; Biomarkers; Docetaxel; Dose-Response Relationship, Drug; Humans; Paclitaxel; Peripheral Nervous System Diseases; Pharmacogenetics; Precision Medicine | 2021 |
Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colorectal Neoplasms; Docetaxel; Drugs, Chinese Herbal; Fluorouracil; Humans; Leucovorin; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Quality of Life; Randomized Controlled Trials as Topic | 2018 |
Defining risks of taxane neuropathy: insights from randomized clinical trials.
Topics: Axons; Bridged-Ring Compounds; Docetaxel; Drug-Related Side Effects and Adverse Reactions; Humans; Nanoparticles; Neoplasms; Paclitaxel; Peripheral Nervous System Diseases; Randomized Controlled Trials as Topic; Taxoids | 2013 |
Chemotherapy plus estramustine for management of castration-resistant prostate cancer: meta-analysis of randomized controlled trials.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Diseases; Combined Modality Therapy; Docetaxel; Epirubicin; Epothilones; Estramustine; Fatigue; Gastrointestinal Diseases; Hematologic Diseases; Humans; Male; Orchiectomy; Paclitaxel; Peripheral Nervous System Diseases; Prostate-Specific Antigen; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Salvage Therapy; Survival Analysis; Taxoids; Treatment Outcome; Vinblastine | 2014 |
Chemotherapy-induced peripheral neuropathy: Current status and progress.
Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Humans; Models, Neurological; Neural Stem Cells; Neurons; Paclitaxel; Peripheral Nervous System Diseases; Taxoids | 2016 |
Managing taxane toxicities.
Topics: Antineoplastic Agents, Phytogenic; Arthralgia; Bridged-Ring Compounds; Docetaxel; Drug Hypersensitivity; Humans; Neutropenia; Paclitaxel; Peripheral Nervous System Diseases; Taxoids; Thrombocytopenia | 2003 |
[Neurotoxic effects of medications: an update].
Topics: Anti-Retroviral Agents; Antineoplastic Agents; Carboplatin; Cisplatin; Colchicine; Docetaxel; Humans; Interferon-alpha; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Peripheral Nervous System Diseases; Taxoids; Thalidomide | 2004 |
Case report: painful peripheral neuropathy following treatment with docetaxel for breast cancer.
Topics: Activities of Daily Living; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Diabetes Mellitus, Type 1; Disease Progression; Docetaxel; Exercise Therapy; Female; Hand Strength; Humans; Middle Aged; Nurse's Role; Oncology Nursing; Pain; Pain Management; Pain Measurement; Patient Care Team; Peripheral Nervous System Diseases; Quality of Life; Severity of Illness Index; Taxoids | 2005 |
Docetaxel-related side effects and their management.
Topics: Antineoplastic Agents; Asthenia; Docetaxel; Drug Administration Schedule; Drug Hypersensitivity; Drug Monitoring; Evidence-Based Medicine; Fever; Humans; Nail Diseases; Neutropenia; Nurse's Role; Nursing Assessment; Nursing Research; Oncology Nursing; Patient Education as Topic; Peripheral Nervous System Diseases; Practice Guidelines as Topic; Premedication; Research Design; Severity of Illness Index; Taxoids; Water-Electrolyte Imbalance | 2008 |
Taxol (paclitaxel): a novel anti-microtubule agent with remarkable anti-neoplastic activity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Arrhythmias, Cardiac; Cell Cycle; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Docetaxel; Drug Hypersensitivity; Drug Screening Assays, Antitumor; Gastrointestinal Diseases; Humans; Mice; Microtubules; Neoplasms; Neoplasms, Experimental; Neutropenia; Paclitaxel; Peripheral Nervous System Diseases; Polyethylene Glycols; Taxoids; Tubulin | 1994 |
[Peripheral nervous system neurotoxicity secondary to chemotherapy treatment] .
Topics: Anti-HIV Agents; Antineoplastic Agents; Cyclosporine; Depsipeptides; Docetaxel; Doxorubicin; Humans; Neoplasms; Neuromuscular Diseases; Oligopeptides; Organoplatinum Compounds; Paclitaxel; Peripheral Nervous System Diseases; Procarbazine; Reverse Transcriptase Inhibitors; Suramin; Taxoids; Vinca Alkaloids | 2000 |
13 trial(s) available for docetaxel anhydrous and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Effect of Exercise on Taxane Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer: A Randomized Controlled Trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Exercise Therapy; Female; Follow-Up Studies; Humans; Middle Aged; Paclitaxel; Peripheral Nervous System Diseases; Prognosis; Quality of Life; Survival Rate | 2019 |
Multicenter randomized controlled trial to evaluate the efficacy and tolerability of frozen gloves for the prevention of chemotherapy-induced peripheral neuropathy.
Topics: Antineoplastic Agents; Docetaxel; Freezing; Gloves, Protective; Humans; Hypothermia, Induced; Neoplasms; Peripheral Nervous System Diseases; Quality of Life; Surveys and Questionnaires | 2020 |
Study Protocol for Assessing the Efficacy of Compression Therapy Using Stockings and Sleeves to Prevent Docetaxel-Induced Peripheral Neuropathy in Breast Cancer Patients.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Compression Bandages; Docetaxel; Female; Humans; Middle Aged; Peripheral Nervous System Diseases | 2020 |
Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Doxorubicin; Drug Administration Schedule; Female; Humans; Middle Aged; Peripheral Nervous System Diseases; Quality of Life; Taxoids | 2018 |
Impact of cabazitaxel on 2-year survival and palliation of tumour-related pain in men with metastatic castration-resistant prostate cancer treated in the TROPIC trial.
Topics: Aged; Aged, 80 and over; Analgesics; Antineoplastic Agents; Docetaxel; Humans; Male; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Pain; Pain Measurement; Palliative Care; Peripheral Nervous System Diseases; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Survival; Survival Rate; Taxoids; Treatment Outcome | 2013 |
Neurotoxicity in ovarian cancer patients on Gynecologic Oncology Group (GOG) protocol 218: characteristics associated with toxicity and the effect of substitution with docetaxel: an NRG Oncology/Gynecologic Oncology Group study.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Docetaxel; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Peripheral Nervous System Diseases; Quality of Life; Taxoids | 2015 |
Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Docetaxel; Epirubicin; Female; Humans; Longitudinal Studies; Middle Aged; Peripheral Nervous System Diseases; Quality of Life; Self Report; Survivors; Taxoids; Young Adult | 2015 |
Low-dose capecitabine plus docetaxel as first-line therapy for metastatic breast cancer: phase II results.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Carcinoma; Cyclophosphamide; Deoxycytidine; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neutropenia; Paclitaxel; Peripheral Nervous System Diseases; Taxoids; Treatment Outcome | 2009 |
Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Docetaxel; Female; Humans; Middle Aged; Neurotoxicity Syndromes; Paclitaxel; Paresthesia; Peripheral Nervous System Diseases; Quality of Life; Surveys and Questionnaires; Taxoids | 2012 |
A phase II trial of neoadjuvant docetaxel and capecitabine for locally advanced breast cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deoxycytidine; Diarrhea; Docetaxel; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Infusions, Intravenous; Middle Aged; Neoadjuvant Therapy; Neutropenia; Peripheral Nervous System Diseases; Taxoids; Treatment Outcome | 2004 |
Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Confidence Intervals; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Humans; Middle Aged; Neutropenia; Odds Ratio; Ovarian Neoplasms; Paclitaxel; Peripheral Nervous System Diseases; Peritoneal Neoplasms; Proportional Hazards Models; Quality of Life; Survival Analysis; Taxoids; Treatment Outcome | 2004 |
A randomized phase II study of ixabepilone (BMS-247550) given daily x 5 days every 3 weeks or weekly in patients with metastatic or recurrent squamous cell cancer of the head and neck: an Eastern Cooperative Oncology Group study.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Epothilones; Female; Head and Neck Neoplasms; Hematologic Diseases; Humans; Infusions, Intravenous; Male; Middle Aged; Paclitaxel; Peripheral Nervous System Diseases; Recurrence; Salvage Therapy; Survival Analysis; Taxoids | 2008 |
Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deoxycytidine; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Gastrointestinal Diseases; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Metastasis; Paclitaxel; Peripheral Nervous System Diseases; Survival Analysis; Taxoids; Treatment Outcome | 2002 |
50 other study(ies) available for docetaxel anhydrous and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Diagnostic tools should be used for the diagnosis of chemotherapy induced peripheral neuropathy in breast cancer patients receiving taxanes.
Topics: Antineoplastic Agents; Breast Neoplasms; Docetaxel; Female; Humans; Paclitaxel; Peripheral Nervous System Diseases | 2022 |
Association of Taxane Type With Patient-Reported Chemotherapy-Induced Peripheral Neuropathy Among Patients With Breast Cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cohort Studies; Docetaxel; Female; Humans; Middle Aged; Paclitaxel; Patient Reported Outcome Measures; Peripheral Nervous System Diseases; Prospective Studies; Quality of Life; Taxoids | 2022 |
[Comparative Safety Study of Original and Generic Docetaxel without Alcohol in the Treatment of Breast Cancer].
Topics: Antineoplastic Agents; Breast Neoplasms; Docetaxel; Edema; Ethanol; Female; Humans; Peripheral Nervous System Diseases; Retrospective Studies; Taxoids | 2022 |
An Evaluation of the Efficacy of Compression Therapy Using Sleeves and Stockings to Prevent Docetaxel-induced Peripheral Neuropathy in Breast Cancer Patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Female; Humans; Peripheral Nervous System Diseases; Retrospective Studies; Taxoids | 2022 |
Taxane-Induced Peripheral Neuropathy: Objective and Subjective Comparison Between Paclitaxel and Docetaxel in Patients With Breast Cancer.
Topics: Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cross-Sectional Studies; Docetaxel; Female; Humans; Middle Aged; Paclitaxel; Peripheral Nervous System Diseases; Quality of Life | 2019 |
Safety and tolerability of cryocompression as a method of enhanced limb hypothermia to reduce taxane-induced peripheral neuropathy.
Topics: Adult; Aged; Cryotherapy; Docetaxel; Extremities; Female; Humans; Hypothermia, Induced; Male; Middle Aged; Neoplasms; Neurotoxicity Syndromes; Paclitaxel; Peripheral Nervous System Diseases; Pilot Projects; Retrospective Studies; Treatment Outcome | 2020 |
Behavioral, Electrophysiological, and Histological Characterization of a New Rat Model for Neoadjuvant Chemotherapy-Induced Neuropathic Pain: Therapeutic Potential of Duloxetine and Allopregnanolone Concomitant Treatment.
Topics: Analgesics; Animals; Antineoplastic Agents; Disease Models, Animal; Docetaxel; Duloxetine Hydrochloride; Epirubicin; Female; Neoadjuvant Therapy; Neuralgia; Pain; Pain Measurement; Peripheral Nervous System Diseases; Pregnanolone; Sciatic Nerve | 2020 |
Chemotherapy-induced peripheral neuropathy among patients with ovarian cancer.
Topics: Adult; Antineoplastic Agents; Case-Control Studies; China; Docetaxel; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Peripheral Nervous System Diseases; Retrospective Studies; Surveys and Questionnaires | 2020 |
Taxane-induced sensory peripheral neuropathy is associated with an SCN9A single nucleotide polymorphism in Japanese patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Japan; Middle Aged; NAV1.7 Voltage-Gated Sodium Channel; Ovarian Neoplasms; Paclitaxel; Peripheral Nervous System Diseases; Polymorphism, Single Nucleotide; Prognosis; Prospective Studies; Survival Rate | 2020 |
Appropriate Number of Docetaxel Cycles in Castration-Resistant Prostate Cancer Patients Considering Peripheral Neuropathy and Oncological Control.
Topics: Aged; Aged, 80 and over; Dexamethasone; Docetaxel; Drug Administration Schedule; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Prednisone; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Survival Rate | 2020 |
Pronociceptive Roles of Schwann Cell-Derived Galectin-3 in Taxane-Induced Peripheral Neuropathy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blood Proteins; Cell Movement; Chemotaxis; Clodronic Acid; Disease Models, Animal; Docetaxel; Female; Galectins; Humans; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Paclitaxel; Pain Perception; Peripheral Nervous System Diseases; Prospective Studies; Rats; Schwann Cells; Sciatic Nerve; Up-Regulation | 2021 |
Neurophysiologic assessment of small fibre damage in chemotherapy-induced peripheral neuropathy.
Topics: Adult; Aged; Antineoplastic Agents; Cross-Sectional Studies; Docetaxel; Electromyography; Female; Humans; Laser-Evoked Potentials; Male; Middle Aged; Nerve Fibers; Oxaliplatin; Peripheral Nervous System Diseases | 2021 |
Predictors of the usefulness of duloxetine for chemotherapy-induced peripheral neuropathy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Body Height; Docetaxel; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Quality of Life; Retrospective Studies; ROC Curve; Taxoids | 2017 |
Long-term peripheral neuropathy symptoms in breast cancer survivors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Cancer Survivors; Cross-Sectional Studies; Docetaxel; Female; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; Peripheral Nervous System Diseases; Prevalence; Retrospective Studies; Taxoids | 2017 |
Chronic Pain and Neuropathy Following Adjuvant Chemotherapy.
Topics: Adult; Aged; Chemotherapy, Adjuvant; Chronic Pain; Cross-Sectional Studies; Docetaxel; Female; Humans; Male; Middle Aged; Oxaliplatin; Peripheral Nervous System Diseases; Retrospective Studies | 2018 |
The Relationship Between Peripheral Neuropathy Induced by Docetaxel and Systemic Inflammation-based Parameters in Patients with Breast Cancer.
Topics: Adult; Aged; Antineoplastic Agents; Blood Platelets; Breast Neoplasms; Docetaxel; Female; Humans; Inflammation; Leukocyte Count; Lymphocytes; Middle Aged; Monocytes; Neutrophils; Peripheral Nervous System Diseases; Platelet Count; Retrospective Studies; Taxoids | 2017 |
Phosphatidylcholine attenuated docetaxel-induced peripheral neurotoxicity in rats.
Topics: Animals; Antineoplastic Agents; Body Weight; Docetaxel; Male; Neuroprotective Agents; Oxidative Stress; Pain Threshold; Peripheral Nervous System Diseases; Phosphatidylcholines; Rats; Rats, Sprague-Dawley; Sciatic Nerve | 2018 |
Chemotherapy-induced peripheral neuropathy: evidence from genome-wide association studies and replication within multiple myeloma patients.
Topics: Aged; Bortezomib; Docetaxel; Drug-Related Side Effects and Adverse Reactions; Female; Genome-Wide Association Study; Humans; Male; Middle Aged; Multiple Myeloma; Nervous System; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Peripheral Nervous System Diseases; Polymorphism, Single Nucleotide; Risk Factors; Taxoids; Vincristine | 2018 |
Risk of incident claims for chemotherapy-induced peripheral neuropathy among women with breast cancer in a Medicare population.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cohort Studies; Docetaxel; Female; Humans; Incidence; Medicare; Paclitaxel; Peripheral Nervous System Diseases; Retrospective Studies; SEER Program; United States | 2019 |
Polymorphic Variants in NR1I3 and UGT2B7 Predict Taxane Neurotoxicity and Have Prognostic Relevance in Patients With Breast Cancer: A Case-Control Study.
Topics: Antineoplastic Agents; Biomarkers, Pharmacological; Breast Neoplasms; Case-Control Studies; Constitutive Androstane Receptor; Docetaxel; Female; Glucuronosyltransferase; Humans; Middle Aged; Outcome Assessment, Health Care; Paclitaxel; Peripheral Nervous System Diseases; Pharmacogenomic Testing; Polymorphism, Single Nucleotide; Prognosis; Receptors, Cytoplasmic and Nuclear | 2019 |
Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy.
Topics: Antineoplastic Agents; Bridged-Ring Compounds; Cancer Care Facilities; Cisplatin; Docetaxel; Female; Hong Kong; Humans; Male; Middle Aged; Neurotoxicity Syndromes; Peripheral Nervous System Diseases; Platinum Compounds; Prevalence; Prospective Studies; Quality of Life; Risk Factors; Taxoids | 2019 |
Patient-reported and clinician-reported chemotherapy-induced peripheral neuropathy in patients with early breast cancer: Current clinical practice.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Female; Humans; Middle Aged; Oncologists; Paclitaxel; Patient Reported Outcome Measures; Peripheral Nervous System Diseases; Self Report; Young Adult | 2019 |
Impact of chemotherapy-induced peripheral neuropathy on treatment delivery in nonmetastatic breast cancer.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Paclitaxel; Pennsylvania; Peripheral Nervous System Diseases; Retrospective Studies; Taxoids | 2013 |
Risk of docetaxel-induced peripheral neuropathy among 1,725 Danish patients with early stage breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Denmark; Docetaxel; Female; Humans; Middle Aged; Neoplasm Grading; Neoplasm Staging; Peripheral Nervous System Diseases; Risk Factors; Taxoids; Young Adult | 2013 |
Evaluation of the Semmes-Weinstein filaments and a questionnaire to assess chemotherapy-induced peripheral neuropathy.
Topics: Adult; Antineoplastic Agents; Brazil; Cross-Sectional Studies; Docetaxel; Female; Humans; Male; Middle Aged; Neoplasms; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Peripheral Nervous System Diseases; Psychometrics; Severity of Illness Index; Surveys and Questionnaires; Taxoids | 2014 |
Docetaxel-induced neuropathy: a pharmacogenetic case-control study of 150 women with early-stage breast cancer.
Topics: Adult; Aged; Alleles; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; Body Mass Index; Breast Neoplasms; Case-Control Studies; Confidence Intervals; Cyclophosphamide; Docetaxel; Epirubicin; Female; Glutathione S-Transferase pi; Haplotypes; Humans; Middle Aged; Odds Ratio; Oxidative Stress; Peripheral Nervous System Diseases; Polymorphism, Genetic; Taxoids | 2015 |
Analysis of Side Effect Profile of Alopecia, Nail Changes, Peripheral Neuropathy, and Dysgeusia in Prostate Cancer Patients Treated With Docetaxel and Cabazitaxel.
Topics: Alopecia; Clinical Trials as Topic; Docetaxel; Drug-Related Side Effects and Adverse Reactions; Dysgeusia; Humans; Male; Nail Diseases; Peripheral Nervous System Diseases; Prospective Studies; Prostatic Neoplasms; Retrospective Studies; Taxoids | 2015 |
Chemotherapy-induced peripheral neuropathy after neoadjuvant or adjuvant treatment of breast cancer: a prospective cohort study.
Topics: Adjuvants, Pharmaceutic; Antineoplastic Agents; Breast Neoplasms; Docetaxel; Female; Humans; Middle Aged; Neoadjuvant Therapy; Patient Outcome Assessment; Peripheral Nervous System Diseases; Prospective Studies; Taxoids | 2016 |
Chemotherapy-induced pain and neuropathy: a prospective study in patients treated with adjuvant oxaliplatin or docetaxel.
Topics: Adult; Aged; Antineoplastic Agents; Docetaxel; Female; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Pain; Peripheral Nervous System Diseases; Prospective Studies; Quality of Life; Surveys and Questionnaires; Taxoids | 2016 |
Relationship between GSTP1 Ile(105)Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity.
Topics: Aged; Antineoplastic Agents, Phytogenic; Docetaxel; Female; Glutathione Transferase; Humans; Isoleucine; Male; Middle Aged; Oxidative Stress; Peripheral Nervous System Diseases; Polymorphism, Genetic; Taxoids; Valine | 2009 |
Docetaxel-induced peripheral neuropathy: protective effects of dihydroprogesterone and progesterone in an experimental model.
Topics: 20-alpha-Dihydroprogesterone; Analysis of Variance; Animals; Body Weight; Disease Models, Animal; Docetaxel; Gene Expression Regulation; Male; Myelin Basic Protein; Myelin P0 Protein; Myelin Proteins; Nerve Fibers; Neural Conduction; Neuroprotective Agents; Pain Threshold; Peripheral Nervous System Diseases; Progesterone; Rats; Rats, Inbred F344; Sciatic Nerve; Taxoids | 2009 |
Unilateral taxane-induced onychopathy in a patient with a brain metastasis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Capecitabine; Carboplatin; Combined Modality Therapy; Deoxycytidine; Docetaxel; Fatal Outcome; Female; Fluorouracil; Hand; Humans; Lapatinib; Middle Aged; Onycholysis; Paclitaxel; Paresis; Peripheral Nervous System Diseases; Quinazolines; Taxoids; Trastuzumab; Vinblastine; Vinorelbine | 2009 |
The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Docetaxel; Drug Interactions; Erythropoietin; Female; Humans; Neuroprotective Agents; Peripheral Nervous System Diseases; Rats; Rats, Inbred F344; Taxoids; Xenograft Model Antitumor Assays | 2010 |
Different effects of erythropoietin in cisplatin- and docetaxel-induced neurotoxicity: an in vitro study.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Cisplatin; Docetaxel; Erythropoietin; Ganglia, Spinal; Nerve Degeneration; Neuroprotective Agents; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Sensory Receptor Cells; Signal Transduction; Taxoids | 2010 |
New recommendation of doses in an ongoing phase II study of docetaxel, oxaliplatin and capecitabine as first line therapy in advanced gastro-oesophageal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Clinical Trials, Phase II as Topic; Denmark; Deoxycytidine; Diarrhea; Docetaxel; Drug Administration Schedule; Esophageal Neoplasms; Fever; Fluorouracil; Humans; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Practice Guidelines as Topic; Stomach Neoplasms; Survival Analysis; Taxoids; Treatment Outcome | 2011 |
Falls in persons with chemotherapy-induced peripheral neuropathy.
Topics: Accidental Falls; Antineoplastic Combined Chemotherapy Protocols; Causality; Comorbidity; Docetaxel; Female; Humans; Logistic Models; Male; Middle Aged; Muscle Weakness; Neoplasm Staging; Neoplasms; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Peripheral Nervous System Diseases; Population Surveillance; Postural Balance; Prospective Studies; Risk Factors; Sensation Disorders; Severity of Illness Index; Surveys and Questionnaires; Taxoids | 2012 |
Case report of a patient with chemotherapy-induced peripheral neuropathy treated with manual therapy (massage).
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Esophageal Neoplasms; Humans; Male; Massage; Middle Aged; Neurotoxicity Syndromes; Peripheral Nervous System Diseases; Quality of Life; Taxoids | 2011 |
Precise evaluation of chemotherapy-induced peripheral neuropathy using the visual analogue scale: a quantitative and comparative analysis of neuropathy occurring with paclitaxel-carboplatin and docetaxel-carboplatin therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Female; Humans; Male; Middle Aged; Neoplasms; Paclitaxel; Pain Measurement; Peripheral Nervous System Diseases; Surveys and Questionnaires; Taxoids | 2012 |
Scope of symptoms and self-management strategies for chemotherapy-induced peripheral neuropathy in breast cancer patients.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Docetaxel; Female; Humans; Middle Aged; Paclitaxel; Pennsylvania; Peripheral Nervous System Diseases; Self Care; Taxoids; Young Adult | 2012 |
Taxane-induced peripheral neuropathy has good long-term prognosis: a 1- to 13-year evaluation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Docetaxel; Electromyography; Evoked Potentials, Motor; Female; Genital Neoplasms, Female; Humans; Longitudinal Studies; Middle Aged; Neural Conduction; Neurologic Examination; Paclitaxel; Peripheral Nerves; Peripheral Nervous System Diseases; Taxoids; Time Factors | 2012 |
Improvement of paclitaxel-induced neuropathy by substitution of docetaxel for paclitaxel.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Humans; Middle Aged; Paclitaxel; Peripheral Nervous System Diseases; Taxoids | 2003 |
Docetaxel versus paclitaxel for adjuvant treatment of ovarian cancer: case-control analysis of toxicity.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Case-Control Studies; Chemotherapy, Adjuvant; Docetaxel; Female; Humans; Middle Aged; Neutropenia; Ovarian Neoplasms; Paclitaxel; Peripheral Nervous System Diseases; Retrospective Studies; Taxoids; Treatment Outcome | 2004 |
[Retrospective analysis on efficacy and toxicity of paclitaxel-containing treatments in patients with advanced or recurrent breast cancer].
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Liver Neoplasms; Middle Aged; Nausea; Neoplasm Recurrence, Local; Paclitaxel; Peripheral Nervous System Diseases; Proportional Hazards Models; Retrospective Studies; Survival Rate; Taxoids; Trastuzumab; Vomiting, Anticipatory | 2004 |
[Combination chemotherapy with docetaxel+carboplatin in the treatment of cancer of the ovary and fallopian tube].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Docetaxel; Drug Administration Schedule; Edema; Fallopian Tube Neoplasms; Female; Humans; Leukopenia; Middle Aged; Neutropenia; Ovarian Neoplasms; Peripheral Nervous System Diseases; Taxoids | 2004 |
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats.
Topics: Analysis of Variance; Animals; Antineoplastic Agents, Phytogenic; Docetaxel; Female; Microtubules; Nerve Fibers, Myelinated; Nerve Growth Factor; Paclitaxel; Peripheral Nervous System Diseases; Rats; Rats, Wistar; Taxoids | 2005 |
Toxic effects differ in combination treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colony-Stimulating Factors; Docetaxel; Doxorubicin; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Paclitaxel; Peripheral Nervous System Diseases; Taxoids | 2007 |
Peripheral neurotoxicity induced by docetaxel.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Agents, Phytogenic; Docetaxel; Female; Humans; Male; Middle Aged; Paclitaxel; Peripheral Nervous System Diseases; Taxoids | 1996 |
Peripheral neuropathy secondary to docetaxel (Taxotere)
Topics: Antineoplastic Agents, Phytogenic; Docetaxel; Electromyography; Humans; Male; Middle Aged; Paclitaxel; Peripheral Nervous System Diseases; Taxoids | 1996 |
Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere).
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Docetaxel; Female; Humans; Male; Middle Aged; Paclitaxel; Peripheral Nervous System Diseases; Taxoids | 1997 |
Docetaxel neuropathy: a distal axonopathy.
Topics: Antineoplastic Agents, Phytogenic; Axons; Docetaxel; Humans; Male; Middle Aged; Nerve Fibers, Myelinated; Paclitaxel; Peripheral Nervous System Diseases; Taxoids | 1999 |